Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial

[1]  P J Kelly,et al.  Postpartum hemorrhage in resource‐poor settings , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[2]  C. AbouZahr,et al.  Maternal Mortality: A Global Factbook , 1991 .

[3]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.

[4]  G. Hofmeyr,et al.  Side-effects of oral misoprostol in the third stage of labour--a randomised placebo-controlled trial. , 2001, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[5]  K. Matthews,et al.  A double‐blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour , 2000, BJOG : an international journal of obstetrics and gynaecology.

[6]  M. Geary,et al.  The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management , 2000, BJOG : an international journal of obstetrics and gynaecology.

[7]  Nyein Nyein Lwin,et al.  Maternal mortality in 2000: estimates developed by WHO, UNICEF and UNFPA. , 2004 .

[8]  Suellen Miller,et al.  Prevention and treatment of postpartum hemorrhage: new advances for low-resource settings. , 2004, Journal of midwifery & women's health.

[9]  L. Morison,et al.  Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial , 2005, BJOG : an international journal of obstetrics and gynaecology.

[10]  D. Selo-Ojeme.  Primary postpartum haemorrhage , 2002, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[11]  A. Faúndes,et al.  Misoprostol for prevention of postpartum hemorrhage , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[12]  K. Cheung,et al.  IS-128 Randomized Controlled Trial of Oral Misoprostol and Intra-muscular Syntometrine in the Management of the Third Stage of Labour , 2001 .

[13]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[14]  R. Horton,et al.  Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. , 2005, Saudi medical journal.

[15]  G. Piaggio,et al.  WHO multicentre randomised trial of misoprostol in the management of the third stage of labour , 2001, The Lancet.

[16]  S. Rusakaniko,et al.  Misoprostol versus oxytocin in the third stage of labor , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[17]  L. Tang,et al.  A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour. , 2001, Human reproduction.

[18]  S. Goudar,et al.  Conducting International Collaborative Research in Developing Nations , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[19]  G. Piaggio,et al.  Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour , 2002, BJOG : an international journal of obstetrics and gynaecology.

[20]  D. Pelletier,et al.  An analysis of anemia and pregnancy-related maternal mortality. , 2001, The Journal of nutrition.

[21]  B. S. Dhillon,et al.  Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[22]  J. Fleiss,et al.  A simple approximation for calculating sample sizes for comparing independent proportions. , 1980, Biometrics.

[23]  E. Zachariah,et al.  Oral misoprostol in the third stage of labor , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[24]  S. Goudar,et al.  Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India. , 2004, International journal of fertility and women's medicine.

[25]  N. Benowitz,et al.  Absorption Kinetics of Misoprostol With Oral or Vaginal Administration , 1997, Obstetrics and gynecology.

[26]  N. Moss,et al.  Drape estimation vs. visual assessment for estimating postpartum hemorrhage , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[27]  B. Winikoff,et al.  Misoprostol for Women's Health: A Review , 2002, Obstetrics and gynecology.

[28]  B. Dilbaz,et al.  Oral Misoprostol for the Third Stage of Labor: A Randomized Controlled Trial , 2003, Obstetrics and gynecology.

[29]  R. Gibbs.  Clinical Risk Factors for Puerperal Infection , 1980, Obstetrics and gynecology.

[30]  C. Langenbach.  Misoprostol in preventing postpartum hemorrhage: A meta‐analysis , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[31]  John Hoey,et al.  Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors , 2005, The Lancet.

[32]  R. Stearn.  SYNTOMETRINE IN THE MANAGEMENT OF THE THIRD STAGE OF LABOUR , 1963, The Journal of obstetrics and gynaecology of the British Commonwealth.

[33]  P. Aaby,et al.  Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial , 2005, BMJ : British Medical Journal.

[34]  Anita E. Larsson,et al.  Routine oxytocin in the third stage of labour: a placebo controlled randomised trial , 1997, British journal of obstetrics and gynaecology.

[35]  C. Mittermayer,et al.  The role of soluble adhesion molecules in evaluating endothelial cell activation in preeclampsia. , 1999, American journal of obstetrics and gynecology.

[36]  P. Darney.  Misoprostol: a boon to safe motherhood…or not? , 2001, The Lancet.

[37]  V. Oboro,et al.  A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour , 2003, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[38]  J. Pritchard,et al.  BLOOD VOLUME CHANGES IN PREGNANCY AND THE PUERPERIUM. III. WHOLE BODY AND LARGE VESSEL HEMATOCRITS IN PREGNANT AND NONPREGNANT WOMEN. , 1962, American journal of obstetrics and gynecology.